Alternaturals (ANAS) Stock Overview

Manufactures and distributes supplements and all-natural remedies that are alternatives to prescription drugs. More details

ANAS fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($1M)

Shares are highly illiquid

Latest financial reports are more than a year old

ANAS Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Alternaturals, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Alternaturals
Historical stock prices
Current Share Price	US$0.014
52 Week High	US$0.021
52 Week Low	US$0.0051
Beta	0
1 Month Change	-29.50%
3 Month Change	67.86%
1 Year Change	76.25%
3 Year Change	-40.00%
5 Year Change	-66.23%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	ANAS	US Pharmaceuticals	US Market
7D	0.7%	-1.0%	-1.4%
1Y	76.3%	26.1%	16.0%

Return vs Industry: ANAS exceeded the US Pharmaceuticals industry which returned 26.6% over the past year.

Return vs Market: ANAS exceeded the US Market which returned 16.9% over the past year.

Price Volatility

Is ANAS's price volatile compared to industry and market?
ANAS volatility
ANAS Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.7%
Market Average Movement	6.4%
10% most volatile stocks in US Market	16.4%
10% least volatile stocks in US Market	2.9%

Stable Share Price: ANAS's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine ANAS's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1995	n/a	n/a	n/a

Alternaturals, Inc. manufactures and distributes supplements and all-natural remedies that are alternatives to prescription drugs. Its products include Focamine, an all-natural focus, attention, and concentration promoter for people suffering from ADHD; and Sombium, an alternative sleep aid. The company was formerly known as Zhong Nong Yuan Fang Holdings, Inc. and changed its name to Alternaturals, Inc. in March 2022.

Alternaturals, Inc. Fundamentals Summary

How do Alternaturals's earnings and revenue compare to its market cap?
ANAS fundamental statistics
Market cap	US$1.46m
Earnings (TTM)	-US$381.30k
Revenue (TTM)	n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Is ANAS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ANAS income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$381.30k
Earnings	-US$381.30k

Last Reported Earnings

Sep 30, 2001

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did ANAS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/12/31 15:22
End of Day Share Price	2025/12/31 00:00
Earnings	2001/09/30
Annual Earnings	2000/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alternaturals, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.